Toward Optimum Benefit‐Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology PrinciplesKarthik Venkatakrishnan, Ashley Milton, Neeraj Gupta et al.|Clinical and Translational Science|2016Cited by 27